{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:58:45Z","timestamp":1790132325502,"version":"4.0.1"},"reference-count":39,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.1210\/jc.2016-3690","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:10:40Z","timestamp":1492614640000},"page":"2083-2090","source":"Crossref","is-referenced-by-count":64,"title":["MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group"],"prefix":"10.1210","volume":"102","author":[{"given":"Rachel S.","family":"van Leeuwaarde","sequence":"first","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen M.","family":"Dreijerink","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet G.","family":"Ausems","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke J.","family":"Beijers","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M.","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W.","family":"de Herder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus Medical Center, 3000 WB Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk N.","family":"van der Horst-Schrivers","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, 9700 VG Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine L.","family":"Drent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Endocrinology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Bisschop","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Havekes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra H. M.","family":"Peeters","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud M.","family":"Pijnappel","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R.","family":"Vriens","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D.","family":"Valk","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"issue":"6","key":"2019041120313289900_B1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"2019041120313289900_B2","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.celrep.2017.02.025","article-title":"Enhancer-mediated oncogenic function of the Menin tumor suppressor in breast cancer","volume":"18","author":"Dreijerink","year":"2017","journal-title":"Cell Reports"},{"issue":"3","key":"2019041120313289900_B3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cen.12614","article-title":"Breast cancer risk in MEN1: a cancer genetics perspective","volume":"82","author":"Brennan","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2019041120313289900_B4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/msy.1998.93107","article-title":"The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1","volume":"124","author":"Carty","year":"1998","journal-title":"Surgery"},{"issue":"6","key":"2019041120313289900_B5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","article-title":"Genotype-phenotype analysis in multiple endocrine neoplasia type 1","volume":"137","author":"Kouvaraki","year":"2002","journal-title":"Arch Surg"},{"issue":"5311","key":"2019041120313289900_B6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"2019041120313289900_B7"},{"key":"2019041120313289900_B8","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"Breast-cancer screening: viewpoint of the IARC Working Group","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041120313289900_B9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/bjc.2011.44","article-title":"Increasingly strong reduction in breast cancer mortality due to screening","volume":"104","author":"van Schoor","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"2019041120313289900_B10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/annonc\/mdq447","article-title":"Breast cancer screening case-control study design: impact on breast cancer mortality","volume":"22","author":"Paap","year":"2011","journal-title":"Ann Oncol"},{"issue":"1","key":"2019041120313289900_B11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1158\/1055-9965.EPI-11-0476","article-title":"Mammography screening and risk of breast cancer death: a population-based case-control study","volume":"21","author":"Otto","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041120313289900_B12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/M15-1536","article-title":"Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies","volume":"164","author":"Mandelblatt","year":"2016","journal-title":"Ann Intern Med"},{"issue":"11","key":"2019041120313289900_B13","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"issue":"8","key":"2019041120313289900_B14","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.29469","article-title":"Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition","volume":"137","author":"Romieu","year":"2015","journal-title":"Int J Cancer"},{"key":"2019041120313289900_B15","doi-asserted-by":"crossref","first-page":"d1016","DOI":"10.1136\/bmj.d1016","article-title":"Association of active and passive smoking with risk of breast cohort study","volume":"342","author":"Randolph","year":"2011","journal-title":"BMJ"},{"key":"2019041120313289900_B16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cen.12614","article-title":"Breast cancer risk in MEN1: a cancer genetics perspective","volume":"82","author":"Brennan","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041120313289900_B17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2015-3766","article-title":"Vriens MR1, de Laat JM, Pieterman CR, Valk GD. Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 study group","volume":"101","author":"van Leeuwaarde","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120313289900_B18","unstructured":"Netherlands Comprehensive Cancer Organisation. Netherlands Cancer Registry. Available at: https:\/\/www.iknl.nl\/cijfers\/. Accessed 8 August 2016."},{"issue":"13","key":"2019041120313289900_B19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jnci\/95.13.1012","article-title":"Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"95","author":"Rookus","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"2019041120313289900_B20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnci\/djh211","article-title":"Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"96","author":"Jernstr\u00f6m","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2019041120313289900_B21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10549-013-2823-4","article-title":"Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers","volume":"143","author":"Kotsopoulos","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"2019041120313289900_B22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-006-9441-3","article-title":"Garber J, Osborne M, Fishman D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A, Rayson D, Bellati C. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"105","author":"Kotsopoulos","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2019041120313289900_B23","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/bcr3138","article-title":"Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"14","author":"Kotsopoulos","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2019041120313289900_B24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-008-9977-5","article-title":"Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update","volume":"114","author":"Ginsburg","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2019041120313289900_B25","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1158\/1055-9965.EPI-08-0396","article-title":"Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1\/2 mutation carriers and noncarriers: results from a population-based study","volume":"17","author":"Lee","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9328","key":"2019041120313289900_B26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","article-title":"Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease","volume":"360","author":"Group","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"2019041120313289900_B27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/ijc.28508","article-title":"Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort","volume":"134","author":"Dossus","year":"2014","journal-title":"Int J Cancer"},{"issue":"8","key":"2019041120313289900_B28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jnci\/djt023","article-title":"Active smoking and breast cancer risk: original cohort data and meta-analysis","volume":"105","author":"Gaudet","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2019041120313289900_B29","doi-asserted-by":"crossref","first-page":"1\u20139","DOI":"10.1186\/s12916-016-0708-1","article-title":"Bisschop, Havekes B, Vriens MR, Valk GD. MEN1 redefined, a clinical comparison of mutation- positive and mutation-negative patients. Results from the DutchMEN1 study group","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"2019041120313289900_B30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"issue":"5","key":"2019041120313289900_B31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00050863","article-title":"Recall and selection bias in reporting past alcohol consumption among breast cancer cases","volume":"4","author":"Giovannucci","year":"1993","journal-title":"Cancer Causes Control"},{"issue":"5","key":"2019041120313289900_B32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10552-008-9263-1","article-title":"Physical activity and premenopausal breast cancer: an examination of recall and selection bias","volume":"20","author":"Maruti","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"11","key":"2019041120313289900_B33","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"issue":"7","key":"2019041120313289900_B34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"12","key":"2019041120313289900_B35","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/gim.2016.31","article-title":"Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model","volume":"18","author":"Lee","year":"2016","journal-title":"Genet Med"},{"issue":"9","key":"2019041120313289900_B36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0959-8049(00)00093-9","article-title":"Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?","volume":"36","author":"Eerola","year":"2000","journal-title":"Eur J Cancer"},{"issue":"4","key":"2019041120313289900_B37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"2019041120313289900_B38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1258\/jms.2012.012085","article-title":"Mammographic screening programmes in Europe: organization, coverage and participation","volume":"19","author":"Giordano","year":"2012","journal-title":"J Med Screen"},{"issue":"15","key":"2019041120313289900_B39","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2015.13183","article-title":"Benefits and harms of breast cancer screening: a systematic review","volume":"314","author":"Myers","year":"2015","journal-title":"JAMA"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/6\/2083\/17665139\/jc.2016-3690.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T07:14:35Z","timestamp":1555053275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/6\/2083\/3074045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,3,17]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3690","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,1]]},"published":{"date-parts":[[2017,3,17]]}}}